VOLUME 28 NUMBER 12 DECEMBER 2010 nature biotechnology l e t t e r s Nano-size particles show promise for pulmonary drug delivery, yet their behavior after deposition in the lung remains poorly understood. In this study, a series of near-infrared (NIR) fluorescent nanoparticles were systematically varied in chemical composition, shape, size and surface charge, and their biodistribution and elimination were quantified in rat models after lung instillation. We demonstrate that nanoparticles with hydrodynamic diameter (HD) less than ≈34 nm and a noncationic surface charge translocate rapidly from the lung to mediastinal lymph nodes. Nanoparticles of HD < 6 nm can traffic rapidly from the lungs to lymph nodes and the bloodstream, and then be subsequently cleared by the kidneys. We discuss the importance of these findings for drug delivery, air pollution and carcinogenesis.
l e t t e r s
Nano-size particles show promise for pulmonary drug delivery, yet their behavior after deposition in the lung remains poorly understood. In this study, a series of near-infrared (NIR) fluorescent nanoparticles were systematically varied in chemical composition, shape, size and surface charge, and their biodistribution and elimination were quantified in rat models after lung instillation. We demonstrate that nanoparticles with hydrodynamic diameter (HD) less than ≈34 nm and a noncationic surface charge translocate rapidly from the lung to mediastinal lymph nodes. Nanoparticles of HD < 6 nm can traffic rapidly from the lungs to lymph nodes and the bloodstream, and then be subsequently cleared by the kidneys. We discuss the importance of these findings for drug delivery, air pollution and carcinogenesis.
Nanoparticles have been proposed as diagnostic, therapeutic and thera nostic agents for a wide variety of human diseases [1] [2] [3] . Delivery of nano particles through the lung is receiving increased attention owing to the large lung surface area available and the minimal anatomical barriers limiting access to the body 4 . The behavior of nanoparticles in the lung is also important for understanding the health effects of air pollution. Recent toxicological studies have confirmed that nanosize particles reach deep into the alveolar region of the lungs 5, 6 and can cause severe inflammatory reactions because of their large surface area-tomass ratio 6 . Inhalation of nanoparticles is increasingly recognized as a major cause of adverse health effects and has an especially strong influence on the cardiovascular system and hemostasis, leading to increased cardiovascular morbidity and mortality [6] [7] [8] . Inhaled nanoparticles can pass from the lungs into the bloodstream and extrapulmonary organs 9 . Alveolar macrophagemediated translocation from the lung surface to the regional tracheobronchial lymph nodes has been shown for micrometersized particles 10 . However, this process takes a relatively long time, from several hours to weeks [10] [11] [12] .
Here we study the behavior of nanoparticles in the first hour after administration to the rat lung and attempt to define the key parameters that control their translocation to draining lymph nodes, the bloodstream and the rest of body, and subsequent elimination (that is, clearance). The standard approach for studying the translo cation of inhaled nanoparticles and ultrafine air pollutants from the lungs to extrapulmonary compartments in animals is to perform post mortem analysis of tissues after inhalation of carbonbased particles 13 , radiotracers 9 or neutronactivated metal particles 11, 14, 15 . Compared to these methods, realtime NIR fluorescence imaging provides several advantages for quantifying the process of nanoparticle trafficking, including a low autofluorescence background, realtime imaging, realtime overlay with anatomy and highly sensitive detection of tar gets several millimeters deep in tissue 16 . We systematically varied the chemical composition, size, shape and surface charge of NIR fluores cent nanoparticles to determine how their physicochemical proper ties affect trafficking across the alveolar surface barrier into tissue, and once in the tissue, their biodistribution and clearance. Enabling this study is our intraoperative fluorescenceassisted resection and exploration (FLARE) imaging system, which permits two independ ent channels (700 nm and 800 nm) of NIR fluorescence images to be acquired simultaneously with color video images in real time 17, 18 .
Two distinct families of nanoparticles were engineered with vary ing chemical composition, shape, size and surface charge ( Table 1 and Fig. 1a) . Inorganic/organic hybrid nanoparticles (INPs) emitted at 800 nm. Quantum dots with various core(shell) and organic coat ing ligands were used to produce INPs of various sizes and charges (INP1-INP5; Supplementary Fig. 1 ). Gelfiltration chromatography was used to measure the final HD, which ranged from 5 to 23 nm in PBS (Supplementary Fig. 2 ). It is important to note that the surface charged INPs with either carboxylic (INP3 and INP5) or amino (INP4) groups showed high protein adsorption, which contributed to a significant increase in final HD when exposed to 100% serum 19 . To study the effect of surface charge in detail, we engineered INP1 and INP2 to have zwitterionic and polar coatings, respectively, which eliminated serum protein binding and resulted in a constant HD in PBS and serum 19, 20 . To engineer INPs with HD > 50 nm, we used silica nanospheres doped with quantum dots and conjugated NIR fluorophore CW800 on the silica surface (INP6-INP9). These silica nanoparticles did not associate with serum proteins; thus, the origi nal size was maintained after 1 h serum incubation at 37 °C. Organic rapid translocation of nanoparticles from the lung airspaces to the body l e t t e r s nanoparticles (ONPs) were designed to emit 700 nm NIR fluorescence, which permitted comparison of the effect of nanoparticle chemical composition with 800 nm-emitting INPs.
To investigate the role of HD in the translocation of nanoparticles from the lung to extrapulmonary compartments of the body, we systemati cally increased the size of fluorescent nanoparticles from 5 to 300 nm. Translocation of INP5 (38 nm HD) and larger particles was severely restricted at 30 min after administration ( Supplementary Fig. 3 ), which indicates that the size threshold for rapid translocation of nano particles from lungs to lymph nodes corresponds to an HD <38 nm in serum (Fig. 1b) . Notably, a similar size threshold was found in the ONPs; that is, between 34 nm (ONP3) and 48 nm (ONP4) in HD, suggesting that the rapid translocation from lungs to mediastinal lymph nodes is primarily governed by the size of nanoparticles, irre spective of chemical composition, shape and conformational flexibil ity. For charged nanoparticles, nonspecific adsorption of endogenous proteins, mostly albumins, can result in a large increase in final HD by 10-50 nm ( Supplementary Fig. 2a ) 19, 21 .
Below the size threshold of 34 nm, the surface charge of nano particles is also critical for rapid translocation from lungs to regional lymph nodes (Fig. 1c) . To investigate this effect in detail, we intro duced zwitterionic (INP1 and ONP1), polar (INP2 and ONP2), anionic (INP3 and ONP3) and cationic (INP4) coatings to both INPs and ONPs, and compared the charge effect. First, hydrophilic and neutral organic coatings such as zwitterionic cysteine and polar PEG ligands prevented adsorption of serum proteins 19 and led to rapid 
l e t t e r s translocation of nanoparticles into the mediastinal lymph nodes.
A previous study has shown the importance of surface properties of nanoparticles in hemostasisinducing effects, such as platelet activation, which may lead to thrombosis 13 . On the other hand, the behavior of highly netcharged nanoparticles (chargetovolume ratio >±1) was more complicated. As both anionic and cationic charged molecules quickly adsorb endogenous proteins in the lungs, similar migration results were expected among the batches 19, 21 . The translocation behavior of nanoparticles in the alveolar lining fluid was, however, very different. Carboxylic group-modified INP3 was found in the lymph nodes within 30 min after administration, whereas no significant translocation was observed for the cationic INP4 (Fig. 1c, bottom) , even though they were engineered from the same batch of CdTe(CdSe) nanocrystals. As it is well known that cationiccharged materials can be taken up by cells 22 , sometimes causing acute cytotoxicity, it is likely that cationic particles (INP4) were rapidly taken up by pulmonary macrophages and/or epithe lial cells shortly after administration, making them unavailable for translocation to lymph nodes. As cationic nanoparticles remain in pulmonary cells for a long time, they may cause severe lung injury 23 . Our results are also consistent with recent reports on pulmonary drug delivery systems that suggest that surface charge affects trans location efficiency 24 .
The majority of the nanoparticles administered in this study remained in the lungs, with small amounts rapidly appearing in the mediastinal lymph nodes within 30 min after administration. Even more rapid translocation (in minutes) from the site of deposition to lymph nodes was only observed for smaller nanoparticles. In particular, for the smallest nanoparticles (INP1, 5 nm), migration to the medias tinal lymph nodes was very fast (within 3 min), and there was measur able nanoparticle accumulation in the kidneys and excretion into urine at 30 min after administration (Fig. 2a and Supplementary Video 1) . On the other hand, INP3 (27 nm) showed slower accumulation into lymph nodes (≈10 min) and blood (≈20 min). Most of our ultrasmall nanoparticles were found in the kidneys, with the smallest ones also found in the urine (Fig. 2b and Supplementary Fig. 4) . Because of the zwitterionic surface coating and small HD 19, 25 , there were virtually no nanoparticles trapped in the hepatic clearance route, such as liver, bile and intestine (Fig. 2b and Supplementary Video 2) .
To confirm the qualitative observations made using NIR fluo rescence, we labeled INPs with 99m TcMAS 3 (MAS 3 is Sacetylmer captoacetyltriserine) and repeated experiments to better quantify nanoparticle translocation from the lung airspaces to lymph node, blood and eventually urine (Fig. 2c and Supplementary Figs. 5 and 6 ). Blood clearance was measured by intermittent sampling of the tail vein. The smallmolecule sodium pertechnetate (TcO 4 − ) was used as a control and showed rapid uptake into blood, consistent with direct translocation through the alveolar airblood barrier 9 , excretion into urine and moderate uptake in lymph nodes at 1 h postinstillation. On the other hand, INP1 and INP3 appeared in the blood after a short lag and at concentrations inversely proportional to HD. Because lymph node uptake of nanoparticles was more pronounced than TcO 4 − , this suggests that there could be another pathway for translocation of nanoparticles from lung airspaces into blood, one involving tran sient passage through lymph nodes.
In this study, we have systematically engineered various nanopar ticles to investigate the effect of particle characteristics on the ability of nanoparticles to translocate from the lungs into the lymph nodes and bloodstream, and on their fate in vivo. Although nanoparticles are stable and show a narrow size distribution in PBS, this study suggests that the final HDs as measured in serum, along with surface charge, are critical in determining the ultimate migration, biodistribution and clearance of nanoparticles deposited in the lungs. The key findings of our study are: (i) a size threshold of ≈34 nm determines whether there is rapid transepithelial translocation of nanoparticles from the alveolar luminal surface into the septal interstitium, followed by quick l e t t e r s translocation to the regional draining lymph nodes where further translocation into the bloodstream could occur; (ii) below this size threshold of ≈34 nm, surface charge is a major factor that influences translocation, with zwitterionic, anionic and polar surfaces being permissive and cationic surfaces being restrictive; and (iii) when HD is <6 nm and surface charge is zwitterionic, nanoparticles can enter the bloodstream quickly from the alveolar airspaces and can ultimately be cleared from the body by means of renal filtration. The latter finding represents what we believe to be an initial description of nanoparticle trafficking from the lung airspaces through the body and into the urine.
These findings have implications for the fields of drug delivery, air pollution control and carcinogenesis. Our results might prove use ful to investigators trying to engineer inhaled nanoparticlebased drugs. First, the data are consistent with the literature showing that large (>100 nm) cationic liposomes provide an improved therapeutic window to treat lung diseases. That is, systemic absorption is very low, presumably because these nanoparticles exceed the size and charge thresholds defined above (with whatever systemic absorption is observed probably due to liposome instability). Second, and more importantly, engineering nanoparticlebased drugs to be zwitterionic and <6 nm in HD should result in rapid and high levels of drug in the bloodstream after administration while permitting renal clearance of drug not bound to its target. And finally, noncationic nanoparticles ≤34 nm and ≥6 nm should provide high levels of drug to pulmonary lymph nodes, which could be used to deliver antibiotics and anti inflammatory drugs to treat lung infections, tumor metastases and inflammatory conditions.
With respect to air pollution and carcinogenesis, our data suggest that noncationic nanoparticles with HD in serum ≤34 nm are poten tially the most dangerous in that they rapidly traverse the epithelial barrier, enter regional lymph nodes, and, if ≥6 nm, are not cleared efficiently by the kidneys. Thus, exposure of internal organs and tissues will be maximal. Chemical strategies that alter the size and charge of pollutants to be large (>34 nm) and cationic could potentially mini mize airspacetobody translocation and provide time for mucociliary and/or macrophagemediated clearance. Once in the body and lodged in lymph nodes (that is 6 nm ≤ HD ≤ 34 nm), noncationic nanoparticles could cause inflammation and/or contribute to carcinogenesis. Smaller nanoparticles, such as those ≈5 nm in HD, are of even more concern for carcinogenesis and distal inflammation because they are capable of traveling from the lung to the bloodstream, and once in the blood stream, can potentially reach every tissue and organ in the body 26 .
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Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturebiotechnology/.
